Study results may help surgeons decide on suitable IOLs

Article

Results of an investigation featured in the European Journal of Ophthalmology could help surgeons determine which IOL to use for each patient.

Recent Videos
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
Related Content
The office of the Agence Nationale de Sécurité du Médicament in Saint-Denis, France. ©HJBC – stock.adobe.com

PulseSight Therapeutics submits Clinical Trial Authorisation for phase I trial of PST-611

Hattie Hayes
January 16th 2025
Article

The transferrin vectorised therapy is being investigated for use in patients with dry age-related macular degeneration and geographic atrophy

Higher molar dose and its translation into clinical practice. Led by John Kitchens, MD; Joined by Peter Kaiser, MD

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD
July 22nd 2024
Podcast
A sign outside the US Food and Drug Administration headquarters. Image credit: ©Tada Images – stock.adobe.com

US FDA approves Zeiss MEL 90 excimer laser for myopia, hyperopia and mixed astigmatism

Jordana Joy
January 14th 2025
Article

The laser integrates into the Corneal Refractive Workflow alongside the Visumax 800 and SMILE pro software

A black-and-white photo of a handshake with the logos for Formycon, Klinge Biopharma and Teva over them.

Teva partners with Klinge Biopharma for commercialisation of Formycon’s FYB203 (biosimilar aflibercept)

Hattie Hayes
January 13th 2025
Article

The commercialisation agreement for the biosimilar to aflibercept (Eylea) covers Israel and major parts of Europe, excluding Italy

Bausch + Lomb launches its enVista Aspire monofocal and toric intraocular lenses in the European Union

Bausch + Lomb launches its enVista Aspire monofocal and toric intraocular lenses in the European Union

Martin David Harp
January 13th 2025
Article

The launch follows a CE Mark received in late 2024

A Snellen chart and OCT image scans on a table, with glasses next to them. Image credit: ©izzuan – stock.adobe.com

Study explores possible applications of retinal imaging in schizophrenia detection

Jordana Joy
January 13th 2025
Article

The study built on previous research indicating specific retinal variables can serve as disease-related biomarkers in neurodegenerative diseases

© 2025 MJH Life Sciences

All rights reserved.